Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 19.4B | 16.6B | 13.0B | 15.2B |
| Cost of revenue | 17.3B | 14.6B | 14.4B | 18.2B |
| Gross profit | 2.1B | 2.1B | -1.4B | -3.0B |
| Operating expense | ||||
| Research & development | 777.0M | 720.6M | 713.8M | 985.3M |
| Selling general and admin | 1.5B | 949.4M | 1.2B | 926.4M |
| Other operating expenses | — | — | — | — |
| Operating income | -228.8M | 393.6M | -3.3B | -4.9B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 606.2M | 604.5M | 644.6M | 621.6M |
| Other income expense | 356.0M | 275.8M | 414.1M | 213.5M |
| Pretax income | -479.0M | 64.9M | -3.5B | -5.3B |
| Tax provision | 43.5M | 91.4M | -198.1M | -42.7M |
| Net income | -522.5M | -26.5M | -3.3B | -5.3B |
| Basic EPS | -0.9 | -0.2 | -5.5 | -10.0 |
| Diluted EPS | -0.9 | -0.2 | -5.5 | -10.0 |
| Basic average shares | 567.0M | 656.4M | 604.4M | 528.4M |
| Diluted average shares | 567.0M | 656.4M | 613.1M | 528.4M |
| EBITDA | 441.4M | 1.1B | -2.5B | -4.3B |
| Net income from continuing op. | -522.5M | -26.5M | -3.3B | -5.3B |
| Minority interests | 853.8K | -5.1M | -3.4M | 3.4M |
| Preferred stock dividends | — | — | — | — |